The present invention relates to isolation and characterization of a cDNA corresponding to Na+/H+ antiporter gene from
1-40. (canceled) 41. An isolated cDNA sequence from 42. The cDNA as claimed in 43. A recombinant vector comprising of a regulatory sequence operably linked to the cDNA as claimed in 44. The recombinant vector as claimed in 45. The recombinant vector as claimed in 46. The recombinant vector as claimed in 47. A host cell comprising the recombinant vector as claimed in 48. The host cell as claimed in 49. The host cell as claimed in 50. The host cell as claimed in 51. A method for conferring salt stress tolerance in plant, said method comprising transformation of said plant with recombinant vector as claimed in 52. The method as claimed in 53. The method as claimed in 54. The method as claimed in a. obtaining a suitable explant from a plant, b. co-cultivating the explant with an c. culturing the transformed plant cells to produce the salt stress tolerant plant. 55. The method as claimed in 56. The method as claimed in 57. The method as claimed in 58. The method as claimed in 54, wherein the explant is selected from a group consisting of cotyledons, hypocotyls, leaves, stem and roots. 59. A transgenic plant having tolerance to salt stress comprising the polynucleotide sequence as set forth in SEQ ID NO: 1. 60. The transgenic plant as claimed in 61. The transgenic plant as claimed in 62. The transgenic plant as claimed in 63. A progeny of said transgenic plant as claimed in 64. An isolated promoter functional in plant cells comprising a polynucleotide sequence as set forth in SEQ ID NO: 3. 65. An isolated promoter functional in plant cells comprising at least 200 contiguous nucleotides of the polynucleotide sequence as set forth in SEQ ID NO: 3. 66. A recombinant vector comprising the promoter of 67. The recombinant vector as claimed in 68. A transgenic plant comprising a promoter as claimed in 69. The transgenic plant as claimed in 70. A progeny of said transgenic plant as claimed in 71. A method of producing a transgenic plant comprising transformation of a plant with recombinant vector of 72. The method as claimed in 73. The method as claimed in 74. A method as claimed in d. obtaining a suitable explant from said plant, e. co-cultivating the explant with an f. culturing the transformed plant cells to produce salt stress tolerant plant. 75. The method as claimed in 76. The method as claimed in 77. The method as claimed in 78. The method as claimed in 79. The method as claimed in
This invention relates to plant genes useful for the genetic manipulation of plant characteristics. More specifically, the invention relates to isolation and characterization of cDNA corresponding to antiporter gene from In salt tolerant plants, sodium extrusion from the cytosol and compartmentalization in vacuoles are key processes for Na+ detoxification and cellular osmotic adjustment. These plants accumulate Na+ in vacuoles through the activity of a tonoplast transmebrane protein called Na+/H+ antiporter. The first gene for a plant tonoplast Na+/H+ antiporter, AtNHX1, was isolated from The central importance of vacuolar sequestration has recently been underlined by experiments in which constitutive over-expression of vacuolar transporters has greatly increased salinity tolerance of a range of species. Over expression of an The present invention relates to isolation and characterization of a cDNA corresponding to Na+/H+ antiporter gene from The present invention also relates to isolation and functional characterization of promoter of Na+/H+ antiporter gene from One embodiment of the present invention relates to an isolated DNA fragment coding for antiporter gene comprising a polynucleotide sequence shown in SEQ ID NO: 1, wherein expression of said polynucleotide sequence in plant results in conferring tolerance to abiotic stress as compared to a corresponding wild type plant. Another embodiment of the present invention discloses a polypeptide comprising an amino acid sequence as shown in SEQ ID NO: 2, said polypeptide is encoded by a DNA fragment of antiporter gene comprising a polynucleotide sequence as shown in SEQ ID NO: 1. Further the over expression of antiporter gene confers tolerance to abiotic stress. One aspect of the invention pertains to a recombinant vector comprising of a regulatory sequence operably linked to the polynucleotide sequence set forth in SEQ ID NO: 1. Another aspect of the invention is directed to a method for conferring tolerance to abiotic stress in a plant comprising transforming the plant with a recombinant vector to produce transformed plant cells, culturing the transformed plant cells to obtain an abiotic stress tolerant plant. Further the abiotic stress factor is either salt stress or drought stress. In a preferred embodiment, the present invention teaches a method of producing a transgenic plant by One embodiment of the present invention is directed to a transgenic plant comprising polynucleotide sequence as shown in SEQ ID NO: 1. One aspect of the present invention provides a monocotyledonous or dicotyledonous transgenic plant comprising of a polynucleotide sequence as set forth in SEQ ID NO: 1 in sense direction. One aspect of the present invention provides a monocotyledonous or dicotyledonous transgenic plant comprising of a polynucleotide sequence as set forth in SEQ ID NO: 1 in anti-sense direction. In one aspect, the present invention pertains to an isolated promoter functional in plant cells comprising a polynucleotide sequence set forth in SEQ ID NO: 3. In another aspect, the present invention describes an isolated promoter functional in plant cells comprising a polynucleotide sequence having at least 200 contiguous nucleotides of the polynucleotide sequence as shown in SEQ ID NO: 3. The invention also pertains to a recombinant vector comprising a promoter having polynucleotide sequence as shown in SEQ ID NO: 3 operably linked to a heterologous DNA sequence of interest. One aspect of the present invention discloses a method of producing a transgenic plant comprising transforming the plant with a recombinant vector operably linked to a heterologous DNA sequence of interest, wherein said recombinant vector comprises of a promoter having polynucleotide sequence as shown in SEQ ID NO: 3. Further the invention also relates to a transgenic plant comprising a promoter having polynucleotide sequence as shown in SEQ ID NO: 3. The invention relates to isolation and characterization of a cDNA fragment corresponding to Na+/H+ antiporter gene (PcNHX1) from The present invention also pertains to isolation and functional characterization of promoter region of Na+/H+ antiporter gene (PcNHX1) from One embodiment of the present invention relates to an isolated DNA fragment coding for antiporter gene (PcNHX1) comprising a polynucleotide sequence set forth in SEQ ID NO: 1, wherein expression of said polynucleotide sequence in plant results in conferring tolerance to abiotic stress as compared to a corresponding wild type plant. Further the abiotic stress is either salt stress or drought stress. Another embodiment of the present invention discloses a polypeptide comprising an amino acid sequence set forth in SEQ ID NO: 2, said polypeptide is encoded by a DNA fragment of antiporter gene comprising a polynucleotide sequence as shown in SEQ ID NO: 1. Further the expression of said gene confers tolerance to abiotic stress. One aspect of the invention pertains to a recombinant vector comprising of a regulatory sequence operably linked to the polynucleotide sequence as shown in SEQ ID NO: 1. Another aspect of the invention pertains to a recombinant vector comprising of a regulatory sequence operably linked to at least 250 contiguous nucleotides of the polynucleotide sequence as shown in SEQ ID NO: 1. Another aspect of the invention provides the recombinant vector is a recombinant plant transformation vector. In another embodiment, the present invention provides method for construction of recombinant plant transformation vector namely PcNHX-1301, PcNHX AS-1301, PcNHX-PRM-1301, and PcPRM-1391z. Further the plant transformation vector is either pCAMBIA 1301 or pCAMBIA 1391Z. The invention also pertains to a recombinant vector comprising a regulatory sequence selected from a group consisting of CaMV 35S promoter, actin promoter, maize ubiquitin promoter, and alcohol dehydrogenase promoter. Another embodiment of the invention describes host cell comprising the recombinant vector. Further, the host cell is selected from a group consisting of Another embodiment of the present invention employs a host cell selected from the group of Another embodiment of the present invention employs a host cell selected from the group of One embodiment of the invention is directed to a method for conferring tolerance to abiotic stress in a plant comprising transforming the plant with a recombinant vector to produce transformed plant cells, wherein the recombinant vector comprises a polynucleotide sequence as shown in SEQ ID NO: 1, culturing the transformed plant cells to obtain an abiotic stress tolerant plant. Further, the abiotic stress factor is either salt stress or drought stress. Yet another embodiment of the invention discloses a method of transformation employed to transform plants which is selected from a group consisting of In yet another embodiment, the present invention provides a method of producing a transgenic plant by One aspect of the present invention pertains to a plant used for transformation by a recombinant vector comprising a polynucleotide sequence as shown in SEQ ID NO 1. Further the plant used for transformation includes, but not limited to, monocots and dicots. More preferably the dicot plant is selected from a group consisting of tobacco, tomato, pea, soybean, Still another aspect of the invention relates to the explant used for transformation is selected from a group consisting of cotyledons, hypocotyls, leaves, stem and roots. One embodiment of the present invention provides a transgenic plant having tolerance to abiotic stress comprising polynucleotide sequence as shown in SEQ ID NO: 1 in sense direction. It also relates to the progeny of said transgenic plant. Yet another embodiment of the present invention describes a transgenic plant having tolerance to abiotic stress comprising polynucleotide sequence as shown in SEQ ID NO: 1 in anti-sense direction. Further it also relates to progeny of said transgenic plant. Further the transgenic plant includes, but not limited to, dicots or monocots. More preferably the dicot plant is selected from a group consisting of tobacco, tomato, pea, soybean, One preferred embodiment of the present invention pertains to an isolated promoter functional in plant cells comprising a polynucleotide sequence as shown in SEQ ID NO: 3. Yet another embodiment of the present invention provides a polynucleotide sequence having at least 200 contiguous nucleotides of the polynucleotide sequence as set forth in SEQ ID NO: 3. The invention also pertains to a recombinant vector comprising said promoter operably linked to a heterologous DNA sequence of interest. The invention further describes the heterologous DNA sequence encodes a protein selected from a group consisting of insect resistance protein, a bacterial disease resistance protein, a fungal disease resistance protein, a viral disease resistance protein, a nematode disease resistance protein, a herbicide resistance protein, a protein affecting grain composition or quality, a selectable marker protein, a screenable marker protein, a protein affecting plant agronomic characteristics, and a stress resistance protein. One preferred embodiment of the present invention is directed to a transgenic plant comprising a plant functional promoter having a polynucleotide sequence as shown in SEQ ID NO: 3. It also pertains to progeny of said transgenic plant. In another preferred embodiment, the invention teaches a transgenic plant comprising a plant functional promoter comprising a polynucleotide sequence having at least 200 contiguous nucleotides of the polynucleotide sequence as shown in SEQ ID NO: 3. Further it also provides the progeny of said transgenic plant. One aspect of the present invention discloses a method of producing a transgenic plant comprising transforming the plant with a recombinant vector wherein, said recombinant vector comprises a promoter sequence as shown in SEQ ID NO: 3 and is operably linked to a heterologous DNA sequence of interest. Yet another aspect of the present invention provides method of producing a transgenic plant comprising promoter region having sequence as shown in SEQ ID NO: 3 wherein, the transformation method is selected from a group consisting of Still another aspect of the present invention describes Yet another aspect of the present invention teaches a method of producing a transgenic plant by Further aspect of the present invention pertains to a plant used for transformation by a recombinant vector comprising a promoter having a polynucleotide sequence as shown in SEQ ID NO: 3. Further the plant used for transformation includes, but not limited to, monocots and dicots. More preferably the dicot plant is selected from a group consisting of tobacco, tomato, pea, soybean, A preferred embodiment of the present invention relates to a method for growing Another embodiment of the invention relates to isolation of total RNA from 2) Construction of cDNA Library of Yet another embodiment of the present invention relates to a directionally cloned cDNA library. This library was constructed in Sal I (5( )/Not I (3( ) sites of pSPORT vector (Invitrogen) using poly (A+) RNA as described above. The detailed methodology on construction of cDNA library is discussed in EXAMPLE 3. Several commercially available kits are available for cDNA synthesis from (A+) enriched RNA well known to the people skilled in the art. Kits for cloning cDNA inserts both directionally and randomly are also well known and can be employed. 3) Screening of cDNA Library of Still another embodiment of the present invention relates to isolating the clone for antiporter gene from the cDNA library of The methodological details pertaining to screening of cDNA library is provided in EXAMPLE 4. Still another embodiment of the present invention relates to deriving a complete nucleic acid sequence of both strands of the full length cDNA of PcNHX1. This was determined using the dideoxy chain termination method (Sanger et al., 1977) with an ABI 310 automated DNA sequencer (Perkin-Elmer) and M13 and pUC18 forward and reverse primers. The nucleic acid sequence for PcNHX1 is shown in SEQ ID NO: 1. This sequence was used for conducting homology searches against the sequences deposited in databases annotated and curated at NCBI (National Centre for Biotechnology Information) and its mirror sites. Nucleotide and amino acid alignments were performed using BLAST. Nucleic acid alignments were performed using BLASTN algorithm (Basic Local Alignment Search Tool for nucleotide; Altschul et al., 1997), wherein nucleotide query sequence is searched against nucleotide database. Protein translations from nucleotide query sequence followed by amino acid sequence alignments for deduced protein against protein database was performed using BLASTX. The search result indicates that the gene codes for an antiporter protein. 5) Random Amplification of cDNA Ends Yet another embodiment of the present invention relates to getting the sequence information at the 5′ end of the partial PcNHX1 clone. 5′RACE (Rapid Amplification of cDNA ends) was performed according to the SMART™ RACE kit from Clontech. These methods for procuring 5′ or 3′ sequence information are well known in the art. Detailed procedure followed is given in EXAMPLE 5. Yet another embodiment of the present invention relates to isolating the promoter sequences corresponding to PcNHX1 gene using TAIL PCR which is an efficient way of identifying flanking genomic regions. This method is well known to the people skilled in the art. The flanking regions can also be isolated by screening genomic libraries using cDNA as a probe, which is a time consuming process. The DNA sequence of the promoter is shown as SEQ ID NO: 3. The detail of the methodology followed is given in EXAMPLE 6. A preferred embodiment of the present invention relates to extending the primers for mapping the 5′-end of transcripts for determination of the precise start site(s) for transcription. The detail of the methodology followed is given in EXAMPLE 7. The analysis revealed a transcription start site 234 bp upstream of the translation start site. Yet another embodiment of the present invention relates to studying the effect of abiotic stress on the expression of the PcNHX1 in Yet another embodiment of the present invention relates to cloning the PcNHX1 insert in the sense direction into the BamH1 site of the binary vector pCAMBIA 1301 downstream of CaMV 35S promoter. The gene was also cloned in the antisense orientation into the same restriction site in the same vector. A third construct was made by cloning the PcNHX1 promoter sequence upstream of the PcNHX gene in pCAMBIA 1301. The PcNHX promoter was cloned in the Sal1 and BamH1 sites of the promoter fusion vector pCAMBIA 1391Z upstream of a promoter less GUS gene. See EXAMPLE 9 for detail procedure. Yet another embodiment of the present invention relates to transformation of tobacco explants by standard One embodiment of the invention relates to the production of the transformed rice carrying antiporter gene from Yet another embodiment of the present invention relates to transforming two cultivated varieties of rice, Pusa Basmati and IR-20 through particle bombardment by employing a standard method for transformation of rice well known to the people skilled in the art. Details of the method are provided in EXAMPLE 12. Yet another embodiment of the present invention relates to screening of the rice and tobacco transgenic plants harboring the construct by employing methods known in the art. Yet another embodiment of the present invention is directed to analyzing the salt tolerance conferred by over-expressing PcNHX1 in tobacco transgenic by performing whole plant salt stress treatments (See EXAMPLE 13). Yet another embodiment of the present invention is directed to analyzing the salt tolerance conferred by over-expressing PcNHX1 in rice transgenics by performing whole plant salt stress treatments (See EXAMPLE 13). Yet another embodiment of the present invention relates to checking the functionality of PcNHX1 promoter in transgenic plants. Detailed procedure is mentioned in EXAMPLE 14. The examples given are merely illustrative of the uses, processes and products claimed in this invention, and the practice of the invention itself is not restricted to or by the examples described. For constructing cDNA library, RT-PCR and RACEs, For studying induction kinetics of PcNHX1 through Northern analysis in response to salt and ABA stress, the Salt stress: Plants were stressed with 0.5× MS containing 0.5M NaCl and leaf tissue frozen at 6 h, 12 h, 24 h, 48 h NaCl treatment and 12 h and 24 h after salt withdrawal. ABA treatment: Plants were stressed with 0.5× MS containing 100 M ABA and leaf tissue frozen at 6 h, 12 h, 24 h, 48 h NaCl treatment and 12 h and 24 h after ABA withdrawal. The method being critical for specifically up-regulating the expression levels of transcripts of antiporter gene (PcNHX1) gene, thereby allowing efficient cloning of antiporter (PcNHX1) gene as a cDNA fragment. Total RNA was isolated from pooled leaf tissue of The directionally cloned cDNA library was constructed in Sal I (5( )/Not I (3( ) sites of pSPORT vector (Invitrogen) using poly (A+) RNA as described in EXAMPLE 2. For first strand synthesis, 5 μg of mRNA and 1 μg of primer-adapter as shown in SEQ ID NO 4 was taken in 8 μl volume in a RNAase free eppendorf tube, incubated at 70° C. for 10 minutes, and quickly chilled on ice. After brief centrifugation, 4 μl of 5× first strand buffer (250 mM Tris-HCl (pH-8.3), 175 mM KCl and 15 mm MgCl2), 2 μl of 0.1 M DTT and 1 μl of 10 mM dNTP mix was added. After incubation at 37° C. for 2 min, 5 μl of reverse transcriptase enzyme (200 U/μl) Superscript II RT, Life technologies, USA) was added and incubated at 37° C. for 1 hr. This was followed by second strand synthesis. In this step, the 20 μl first strand reaction mixture, 91 μl of water, 30 μl of 5× second strand buffer (100 mm Tris-HCl, pH 6.9; 450 mM KCl, 23 mM MgCl2; 0.75 b-NAD+; 50 mM (NH4) 2SO4, 3 μl of 10 mM dNTP mix, 1 μl of The ligated cDNA library was transformed into A heterologous probe using NHX1 gene from For screening for the plasmid carrying the antiporter cDNA from In order to procure the missing sequence information at the 5′ end of PcNHX1, 5′ RACE (Rapid Amplification of cDNA Ends) was performed. Primers were designed based on the sequence information from the first clone. Total RNA from 0.5M NaCl, 48 hr stressed First strand cDNA was synthesized using the SMART™ RACE kit (Clontech) according to the manufacture's instructions. When the 5′ RACE reaction following first strand synthesis was run on a 1.5% agarose gel, multiple bands were observed. Southern analysis revealed a band corresponding to 450 bp, which gave the highest signal. This PCR fragment was gel purified and cloned in T/A cloning vector. The 450 bp fragment identified by 5′ RACE and the original 1.875 kb fragment were joined by Splice Overlap Extension (SOE) PCR. The resulting 2.148 bp fragment was gel purified and cloned in T/A cloning vector. Universal primers were used for generating the compiled sequence of the clone. For TAIL-PCR, the gene specific primers originally designed for 5′-RACE were used in combination with arbitrary degenerate primers, originally described by, Leu et al. For primary reaction, In order to accurately map the transcription start site, primer extension assay was carried out using an antisense oligonucleotide derived from the 5′UTR region immediately upstream of the start codon of the PcNHX1 gene. To study the effect of salinity ABA on the expression of the PcNHX1, Northern analysis was performed using total RNAs, isolated from stressed For Northern analysis, equal amounts of total RNA 30 (μg) were electrophoresed on a 1.2% MOPS-formaldehyde gel, transferred to nylon membrane (Hybond N, Amersham) and fixed by UV cross linking according to the manufacturers instructions. A PCR amplified fragment of the PcNHX1 clone was used as a probe. Yet another embodiment of the present invention relates to cloning the PcNHX1 insert in the sense direction into the BamH1 site of the binary vector pCAMBIA 1301 downstream of CaMV 35S promoter. The gene was also cloned in the antisense orientation into the same restriction site in the same vector. A third construct was made by cloning the PcNHX1 promoter sequence upstream of the PcNHX gene in pCAMBIA 1301. The PcNHX promoter was cloned in the Sal1 and BamH1 sites of the promoter fusion vector pCAMBIA 1391Z upstream of a promoter less GUS gene. Plant transformation vector constructs PcNHX-1301, PcNHX AS-1301, PcNHX-PRM-1301, and PcPRM-1391z were transferred to tobacco explants. Transformation of tobacco leaf discs was performed through Two cultivated varieties of indica rice, Pusa Basmati and IR-20, were used for transformation using The embryos were dehusked and surface sterilized with 70% EtOH for 1 minute followed by sterilization with 2% sodium hypochloride for 2 hours. The seeds were subsequently washed in sterile distilled water (5-6 times) and dried on a sterile blotting paper. Finally, the seeds were plated on MS medium containing 2 mg/L 2,4-D for callus induction for 3 weeks. Embryogenic calli were cut into small pieces and pre-cultured for two days before A single colony of the After 48 hrs the calli were washed in 3% MS containing 250 mg/L cefotaxime. The washing was repeated 7-8 times. After washing the calli were dried on filter paper and transferred to selection media. Selection was carried out on plates containing MS+50 mg/L hygromycin+250 mg/L cefotaxime. Second selection After 15 days the growing calli were transferred to fresh selection plates.
For particle bombardment, plasmid DNA was coated on to gold particles and delivered into the calli by using a Bio-Rad PDS-1000/He Biolistic System. Following steps were undertaken: Calli developed from mature seeds were excised into small pieces and transferred to MS plates containing 3 mg/L 2,4-D and sorbitol and Mannitol, 0.2M each. Simultaneously, micro-carriers were prepared. 1.5 mg of gold particles (Biorad, USA) was weighed on a microfuge tube. 10 μg of plasmid DNA was taken in 100 μL Xho Buffer (30 μL of 5M NaCl, 5 μL of 2M TrisCl, pH 8, 965 μL distilled water) and added to the tube containing the gold particles. The contents of the tube were mixed by vortexing. Spermdine (0.1M, 100 μL) was added to the tube and mixed by vortexing. Hundred microlitres of 2.5M CaCl2 was added drop-by-drop while vortexing and incubated on vortex for 10 minutes. The mixture was centrifuged briefly at 13,000 rpm and the supernatant was discarded. The gold pellet was re-suspended in 1 mL 100% EtOH, pelleted and re-suspended in 1 mL 100% EtOH. The contents were vortexed in the suspension briefly and stored in −20° C. For each bombardment, 15 μL of this gold suspension was used after sonicating briefly. After 4 hrs, the macro-carrier launch assembly was sterilized using 70% EtOH. The micro-carrier suspension was vortexed and 15 μL of the micro-carrier suspension was coated on the macro-carrier. Finally, the macro-carrier was placed inside the holder with a sterile forceps. The disc was ruptured and the ruptured disc was inserted to the helium accelerator tube. The stop screen was inserted into the macro-carrier launch assembly. The macro-carrier holder was inserted inside the assembly, and placed inside the chamber. The petri plate containing the calli was placed on the dish holder and inserted into the chamber. The vacuum pump was switched on and was kept at hold. The helium pressure was allowed to build up by pressing the fire switch on. After the bombardment, the vacuum was released by pressing the vent switch. The used rupture disc was removed and macro-carrier was replaced with new ones. Once all the bombardments were over, the plates were returned to 28° C. and incubated for 4 hours. After 4 hours the bombardment was repeated again, and the plate was incubated overnight on the same osmoticum plates. After 16 hrs, the call was transferred to the selection media. After three rounds of selection, the calli was transferred to regeneration media without any antibiotics. The regenerated plants were transferred to MS media with antibiotics and no hormones. The plants were finally transferred to Yoshida solution for hardening in the green house. After 3 weeks, the plants were transplanted to soil. The salt tolerance conferred by over-expressing PcNHX1 in tobacco and rice transgenics was analyzed by performing whole plant salt stress treatments. Phenotypic growth retardation study was also performed between control and transgenic plants. Three control and transgenic plants were grown initially in ½ MS for 1 week. Later, they were transferred to ½ MS medium supplemented with 150 mM and 200 mM NaCl. It was observed that in 150 mM NaCl, transgenic plants showed better rooting when compared to control plants. At 200 mM NaCl, both control and transgenic plants did not root. It was also found that the both tobacco and rice transgenic plants suffered less damage in 150 mM and 200 mM NaCl stress. Phenotypic growth retardation was not evident in transgenic plants (tobacco and rice) grown in pots and irrigated with 150 mM NaCl solution for 1½ weeks. The functionality of PcNHX1 promoter in transgenic plants was tested by fusing the GUS coding sequence to PcNHX1 promoter (see EXAMPLE for construction of these reporters constructs). The constructs thus generated were mobilized into tobacco plants. Leaves from the transgenic tobacco plants carrying the promoter-GUS fusion plasmid, were subjected to a preliminary GUS analysis. Pieces of fresh leaves were incubated in substrate solution (X-Gluc in NaPO4 buffer) overnight.FIELD OF INVENTION
BACKGROUND OF THE INVENTION
SUMMARY OF INVENTION
BRIEF DESCRIPTION OF ACCOMPANYING DRAWINGS
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
1) Plant Growth Conditions
2) RNA Isolation
4) Sequence Characterization and Phylogenetic Analysis of PcNHXI
6) Isolation of the PcNHX1 Promoter Region by TAIL-PCR
7) Primer Extension for Mapping Transcription Initiation Site
8) Kinetics of Induction of PcNHX1 in Response to Abiotic Stresses
9) Construction of Plant Transformation Vectors
10) Transformation of Tobacco Using
11) Transformation of Rice Using
12) Transformation of Rice Through Particle Bombardment
13) Screening of the Transformed Plants
14) Analyzing Salt Tolerance in Tobacco and Rice Transgenics
15) GUS Assay for PcNHX1 Promoter Activity in Tobacco
EXAMPLES
Example 1
Plant Growth Parameters
Plant Growth Conditions
Example 2
RNA Isolation
Example 3
Construction of cDNA Library
(Primer) SEQ ID NO 4 5′-GACTAGT TCTAGA TCGCGA GCGGCCGC CC (T) 15-3′ Example 4
Screening of
Example 5
Random Amplification of cDNA Ends
Example 6
Tail PCR for Isolation of PcNHX1 Promoter Sequences
Example 7
Primer Extension Analysis of the Promoter
Example 8
Northern Analysis for Studying Induction Kinetics of PcNHX1
Example 9
Construction Plant Transformation Vectors
Example 10
Plant Transformation
Transformation of Tobacco Using
Example 11
Transformation of Rice Using
Transformation Method
Washing and First Selection
Third selection After two weeks the calli was transferred again to fresh selection media and cultured for 2 more weeks.
Regeneration After 3 rounds of selection, embryogenic calli were transferred to regeneration media i.e., MS+1.5 mg/L BAP+0.5 mg/L Kinetin+0.5 mg/L NAA without antibiotics. The shooted calli was transferred to 3% MS without hormones and with antibiotic for rooting.
Example 12
Transformation of Rice Through Particle Bombardment
Example 13
Salt Stress Analysis in Transgenic Tobacco and Rice Plants
Whole-Plant Salt Stress Treatments:
Example 14
GUS Assay for NHX Promoter Activity in Tobacco